Cargando…

Anti-nerve growth factor in pain management: current evidence

There continues to be an unmet need for safe and effective pain medications. Opioids and nonsteroidal anti-inflammatory drugs (NSAIDs) dominate the clinical landscape despite limited effectiveness and considerable side-effect profiles. Although significant advancements have identified myriad potenti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chang, David S, Hsu, Eugene, Hottinger, Daniel G, Cohen, Steven P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4908933/ https://www.ncbi.nlm.nih.gov/pubmed/27354823 http://dx.doi.org/10.2147/JPR.S89061

Ejemplares similares

Anti-nerve growth factor monoclonal antibodies for the control of pain in dogs and cats
por: Enomoto, Masataka, et al.
Publicado: (2019)

Role of Nerve Growth Factor in Orofacial Pain
por: Mai, Lijia, et al.
Publicado: (2020)

Postamputation pain: epidemiology, mechanisms, and treatment
por: Hsu, Eugene, et al.
Publicado: (2013)

Nerve Growth Factor Signaling and Its Contribution to Pain
por: Barker, Philip A, et al.
Publicado: (2020)

The Role of Anti-Nerve Growth Factor Monoclonal Antibodies in the Control of Chronic Cancer and Non-Cancer Pain
por: Bimonte, Sabrina, et al.
Publicado: (2021)

Chronic postsurgical pain: current evidence for prevention and management
por: Thapa, Parineeta, et al.
Publicado: (2018)

Response to: “Tanezumab: Therapy targeting nerve growth factor in pain pathogenesis”
por: Tive, Leslie A., et al.
Publicado: (2018)

A canine-specific anti-nerve growth factor antibody alleviates pain and improves mobility and function in dogs with degenerative joint disease-associated pain
por: Lascelles, B Duncan X, et al.
Publicado: (2015)

Tanezumab: Therapy targeting nerve growth factor in pain pathogenesis
por: Patel, Mona K., et al.
Publicado: (2018)

Mechanism and therapeutic effectiveness of nerve growth factor in osteoarthritis pain
por: Shang, Xiushuai, et al.
Publicado: (2017)

Frunevetmab, a felinized anti‐nerve growth factor monoclonal antibody, for the treatment of pain from osteoarthritis in cats
por: Gruen, Margaret E., et al.
Publicado: (2021)

Ultrasound-Guided Nerve Hydrodissection for Pain Management: Rationale, Methods, Current Literature, and Theoretical Mechanisms
por: Lam, King Hei Stanley, et al.
Publicado: (2020)

Tapentadol in the management of cancer pain: current evidence and future perspectives
por: Kress, Hans G, et al.
Publicado: (2019)

Temporal mismatch between pain behaviour, skin Nerve Growth Factor and intra-epidermal nerve fibre density in trigeminal neuropathic pain
por: Evans, Laura J, et al.
Publicado: (2014)

Letter to the Editor: Ketamine for pain management: let's not neglect practical concerns
por: Cohen, Steven P., et al.
Publicado: (2019)

Clonidine for management of chronic pain: A brief review of the current evidences
por: Kumar, Anil, et al.
Publicado: (2014)

Evidence for nerve growth factor-mediated paracrine effects in human epidermis
Publicado: (1991)

In Vitro and In Vivo Characterization of a Fully Felinized Therapeutic Anti‐Nerve Growth Factor Monoclonal Antibody for the Treatment of Pain in Cats
por: Gearing, D.P., et al.
Publicado: (2016)

Treatment of Painful Nerves in the Abdominal Wall Using Processed Nerve Allografts
por: Bi, Andrew, et al.
Publicado: (2018)

Nerve growth factor–mediated photoablation of nociceptors reduces pain behavior in mice
por: Nocchi, Linda, et al.
Publicado: (2019)

The mysterious furcal nerve: Implications in pain management
por: Lal, Ashok, et al.
Publicado: (2023)

The efficacy of nerve growth factor antibody in a mouse model of neuropathic cancer pain
por: Miyagi, Masayuki, et al.
Publicado: (2016)

Efficacy of nerve growth factor antibody in a knee osteoarthritis pain model in mice
por: Miyagi, Masayuki, et al.
Publicado: (2017)

Standards of care and novel approaches in the management of glioblastoma multiforme
por: Hottinger, Andreas F., et al.
Publicado: (2014)

The Benefits of Integrative Medicine for Pain Management in Oncology: A Narrative Review of the Current Evidence
por: Carvalho, Victoria, et al.
Publicado: (2023)

Insulin-Like Growth Factor I and the Pathogenesis of Delirium: A Review of Current Evidence
por: Adamis, Dimitrios, et al.
Publicado: (2011)

Single Cycle Structure-Based Humanization of an Anti-Nerve Growth Factor Therapeutic Antibody
por: Covaceuszach, Sonia, et al.
Publicado: (2012)

Effect of repeated intravitreal anti-vascular endothelial growth factor drugs on corneal nerves
por: Qi, Yuanyuan, et al.
Publicado: (2023)

The Efficacy of Nerve Growth Factor Antibody for the Treatment of Osteoarthritis Pain and Chronic Low-Back Pain: A Meta-Analysis
por: Yang, Si, et al.
Publicado: (2020)

Active immunisation targeting nerve growth factor attenuates chronic pain behaviour in murine osteoarthritis
por: von Loga, Isabell S, et al.
Publicado: (2019)

Mechanisms of nerve growth factor signaling in bone nociceptors and in an animal model of inflammatory bone pain
por: Nencini, Sara, et al.
Publicado: (2017)

Impacts of anti-nerve growth factor antibody on pain-related behaviors and expressions of opioid receptor in spinal dorsal horn and dorsal root ganglia of rats with cancer-induced bone pain
por: Yao, Peng, et al.
Publicado: (2016)

The Peripheral Nerve Surgeon’s Role in the Management of Neuropathic Pain
por: Caragher, Seamus P., et al.
Publicado: (2023)

Augmented pain behavioural responses to intra-articular injection of nerve growth factor in two animal models of osteoarthritis
por: Ashraf, Sadaf, et al.
Publicado: (2014)

Non-pharmacological management of pediatric functional abdominal pain disorders: Current evidence and future perspectives
por: Cordeiro Santos, Maria Luísa, et al.
Publicado: (2022)

NERVE GROWTH FACTOR, NEUROPEPTIDES AND CUTANEOUS NERVES IN ATOPIC DERMATITIS
por: Hodeib, Abeer, et al.
Publicado: (2010)

Treatment of Neuroma-induced Chronic Pain and Management of Nerve Defects with Processed Nerve Allografts
por: Ducic, Ivica, et al.
Publicado: (2019)

Cancer pain management-current status
por: Thapa, Deepak, et al.
Publicado: (2011)

Orofacial pain management: current perspectives
por: Romero-Reyes, Marcela, et al.
Publicado: (2014)

Nerve growth factor antibody for the treatment of osteoarthritis pain and chronic low-back pain: mechanism of action in the context of efficacy and safety
por: Schmelz, Martin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_69unfd77tda0hm161civtgqk0i